Entecavir Prevents HBV Reactivation During Direct Acting Antivirals for HCV/HBV Dual Infection: A Randomized Trial
Pin‐Nan Cheng(National Cheng Kung University Hospital), Pei‐Jer Chen(National Taiwan University), Kuo‐Chih Tseng(Buddhist Tzu Chi General Hospital), Chi-Yi Chen(Chia-Yi Christian Hospital), Cheng‐Yuan Peng(China Medical University), Chun‐Jen Liu(National Taiwan University), Yen‐Cheng Chiu(National Cheng Kung University Hospital), Hung‐Chih Chiu(National Cheng Kung University Hospital), Gin‐Ho Lo(E-Da Hospital), Chih‐Lin Lin(Chung Shan Medical University Hospital)
Cited by 21
Related Papers
Mitotic and G <sub>2</sub> Checkpoint Control: Regulation of 14-3-3 Protein Binding by Phosphorylation of Cdc25C on Serine-216
|Science|1997|1.3k
Global patterns of hepatocellular carcinoma management from diagnosis to death: the <scp>BRIDGE</scp> Study
|Liver International|2015|1.3k
SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma
|Journal of Clinical Oncology|2018|653
Hepatitis B Virus Genotype and DNA Level and Hepatocellular Carcinoma: A Prospective Study in Men
|JNCI Journal of the National Cancer Institute|2005|569